Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
657.40
-3.20 (-0.48%)
Jul 31, 2026, 3:29 PM IST
NSE:AKUMS Market Cap
NSE:AKUMS has a market cap or net worth of 100.79 billion as of July 31, 2026. Its market cap has increased by 22.12% in one year.
Market Cap
100.79B
Enterprise Value
86.08B
Revenue
43.61B
Ranking
n/a
PE Ratio
39.50
Stock Price
657.40
ChartMarket Cap Chart
Since August 6, 2024, NSE:AKUMS's market cap has decreased from 125.32B to 100.79B, a decrease of -19.57%. That is a compound annual growth rate of -10.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 100.79B | 45.20% |
| Dec 31, 2025 | 69.42B | -30.92% |
| Dec 31, 2024 | 100.48B | -19.82% |
| Aug 6, 2024 | 125.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 187.72B |
| NATCO Pharma | 166.55B |
| Cohance Lifesciences | 162.71B |
| Alembic Pharmaceuticals | 156.67B |
| Alivus Life Sciences | 142.38B |
| Sudeep Pharma | 99.51B |
| Strides Pharma Science | 94.48B |
| Sun Pharma Advanced Research Company | 66.92B |